DarioHealth Corp reports results for the quarter ended June 30 - Earnings Summary

DarioHealth

11/08/2026 14:32

DarioHealth Corp DRIO.OQ reported quarterly adjusted earnings of 85 cents​​ per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of $-3.60.  The mean expectation of two analysts for the quarter was for a loss of $1.21 per share. Wall Street expected results to range from $-1.24 to $-1.19 per share.
Revenue fell 3.6% to $5.18 million from a year ago; analysts expected $5.92 million. 
DarioHealth Corp's reported EPS for the quarter was 85 cents​.
The company reported quarterly net income of $7.92 million.
DarioHealth Corp shares had risen by 16.1% this quarter and lost 32.7% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had risen by about 2.8% in the last three months.​ 
In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell." The average consensus recommendation for the medical equipment, supplies & distribution peer group is also "buy" 
Wall Street's median 12-month price target for DarioHealth Corp is $11.50, about 33.4% above its last closing price of $7.66
This summary was machine generated from LSEG data August 11 at 01:31 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING
ESTIMATE 
ACTUAL
BEAT, MET, MISSED
Jun. 30 2026 
-1.21
0.85
Beat
Mar. 31 2026 
-1.48
-1.25
Beat
Dec. 31 2025 
-3.24
-3.43
Missed
Sep. 30 2025 
-4.90
2.96
Beat